Risks of Organ Preservation in Rectal Cancer: Data From Two International Registries on Rectal Cancer

Abstract

Patients with LR appear to have a higher risk for subsequent DM development than patients with nPCR managed by TME at restaging irrespective of final pathology. Leaving the primary undetectable tumor in situ until development of LR may result in worse oncologic outcomes.